title: Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
authors.affiliation: Rockville Centre, NY 11570, USA.
authors.forename: Eric D
authors.initials: ED
authors.lastname: Donnenfeld
authors.forename: Ashley
authors.initials: A
authors.lastname: Donnenfeld
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001577:Benzophenones / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001969:Bromobenzenes / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004334:Drug Administration Schedule; D009877:Endophthalmitis / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D009883:Ophthalmic Solutions; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001577:Benzophenones; D001969:Bromobenzenes; D009883:Ophthalmic Solutions; C053083:bromfenac